Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC
Clinical trial NCT07018947 · RECRUITING
Trial details
- NCT number
- NCT07018947
- Sponsor
- Fundacion Clinic per a la Recerca Biomédica
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-02
- Primary completion
- 2031-06-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.